{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:28:20Z","timestamp":1794551300714,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["STR\/2022\/000008"],"award-info":[{"award-number":["STR\/2022\/000008"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/003028"],"award-info":[{"award-number":["CRG\/2022\/003028"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.141903","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:39:19Z","timestamp":1741455559000},"page":"141903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Deciphering the molecular interactions between monocyte chemoattractant protein and its potential inhibitor suramin"],"prefix":"10.1016","volume":"307","author":[{"given":"Deepak Kumar","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutami","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha Das","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Mohan","family":"Poluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141903_bb0005","first-page":"183","article-title":"Acute inflammation. A review","volume":"86","author":"Ryan","year":"1977","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2741\/4860","article-title":"Molecular insights into kinase mediated signaling pathways of chemokines and their cognate G protein coupled receptors","volume":"25","author":"Tripathi","year":"2020","journal-title":"Front. Biosci."},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.141903_bb0015","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/acs.biochem.7b00129","article-title":"Insights into CC chemokine ligand 2\/chemokine receptor 2 molecular recognition: a step forward toward antichemotactic agents","volume":"56","author":"David","year":"2017","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.141903_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0025","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.141903_bb0030","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbrc.2013.12.117","article-title":"Tumor-conditioned Gr-1+ CD11b+ myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro","volume":"443","author":"Han","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.141903_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1871530315666150316120920","article-title":"CCL2-CCR2 signaling in disease pathogenesis","volume":"15","author":"O\u2019Connor","year":"2015","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141903_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/ph10030070","article-title":"Glycosaminoglycan interactions with chemokines add complexity to a complex system","volume":"10","author":"Proudfoot","year":"2017","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.141903_bb0045","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1073\/pnas.0334864100","article-title":"Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines","volume":"100","author":"Proudfoot","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155503","article-title":"Glycosaminoglycans located on neutrophils and monocytes impact on CXCL8-and CCL2-induced cell migration","volume":"142","author":"Gerlza","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00483","article-title":"Targeting chemokine\u2014glycosaminoglycan interactions to inhibit inflammation","volume":"11","author":"Crijns","year":"2020","journal-title":"Front. Immunol."},{"issue":"9709","key":"10.1016\/j.ijbiomac.2025.141903_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human african trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0065","series-title":"Heparin Analogues: A New Family of Anticancer Drugs","author":"Corliss","year":"1989"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.141903_bb0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jviromet.2011.03.021","article-title":"Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity cellufine sulfate column","volume":"174","author":"Ohtaki","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2025.141903_bb0075","first-page":"87","article-title":"The effect of suramin on healing adult rodent dermal wounds","volume":"186","author":"Chamberlain","year":"1995","journal-title":"J. Anat."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.141903_bb0080","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/molecules13112758","article-title":"Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis","volume":"13","author":"Urbinati","year":"2008","journal-title":"Molecules"},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.141903_bb0085","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.2174\/138161209789058156","article-title":"Polysulfated\/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis","volume":"15","author":"Rusnati","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141903_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s42003-023-04789-z","article-title":"Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions","volume":"6","author":"Kwon","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147888","article-title":"RNA-seq revealed the anti-pyroptotic effect of suramin by suppressing NLRP3\/caspase-1\/GSDMD pathway in LPS-induced MH-S alveolar macrophages","volume":"893","author":"Zhu","year":"2024","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.141903_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036194","article-title":"Suramin alleviates glomerular injury and inflammation in the remnant kidney","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.141903_bb0105","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/acs.jafc.3c01283","article-title":"Gallate moiety of catechin is essential for inhibiting CCL2 chemokine-mediated monocyte recruitment","volume":"71","author":"Tripathi","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112584","article-title":"Molecular insight into the structural and functional aspects of arene Ru (II) complexes bearing bulky thiourea ligands","volume":"257","author":"Pathan","year":"2024","journal-title":"J. Inorg. Biochem."},{"issue":"39","key":"10.1016\/j.ijbiomac.2025.141903_bb0115","doi-asserted-by":"crossref","first-page":"20539","DOI":"10.1074\/jbc.M116.745265","article-title":"Molecular basis of chemokine CXCL5-glycosaminoglycan interactions","volume":"291","author":"Sepuru","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.141903_bb0120","doi-asserted-by":"crossref","first-page":"10306","DOI":"10.1021\/acsomega.1c00655","article-title":"Hydroxyl groups on annular ring-B dictate the affinities of Flavonol\u2013CCL2 chemokine binding interactions","volume":"6","author":"Joshi","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijbiomac.2020.04.067","article-title":"Dissecting the differential structural and dynamics features of CCL2 chemokine orthologs","volume":"156","author":"Joshi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141903_bb0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2930849","article-title":"Nmr and molecular-modelling studies of the solution conformation of heparin","volume":"293","author":"Mulloy","year":"1993","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.141903_bb0135","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein\u2013ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Biological Crystallography"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.141903_bb0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.124218","article-title":"Mechanistic insights into inhibition of CCL2-guided leukocyte recruitment by oxyresveratrol and its derivatives","volume":"398","author":"Tripathi","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.141903_bb0150","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/jacs.6b02682","article-title":"Interaction entropy: a new paradigm for highly efficient and reliable computation of protein\u2013ligand binding free energy","volume":"138","author":"Duan","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.141903_bb0155","doi-asserted-by":"crossref","first-page":"22294","DOI":"10.1074\/jbc.M311224200","article-title":"Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo","volume":"279","author":"Lau","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.141903_bb0160","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discovery"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.141903_bb0165","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7376","article-title":"Targeting the CCL2-CCR2 signaling axis in cancer metastasis","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.141903_bb0170","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2\u2013CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.141903_bb0175","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s43440-021-00280-w","article-title":"Targeting the CCL2-CCR2 axis in depressive disorders","volume":"73","author":"Curzytek","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141903_bb0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1189\/jlb.72.1.24","article-title":"Viral chemokine-binding proteins","volume":"72","author":"Seet","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.141903_bb0185","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20072689","article-title":"Ticks produce highly selective chemokine binding proteins with antiinflammatory activity","volume":"205","author":"D\u00e9ruaz","year":"2008","journal-title":"J. Exp. Med."},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.141903_bb0190","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.1074\/jbc.RA119.008902","article-title":"Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2","volume":"294","author":"Denisov","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.matbio.2018.01.011","article-title":"TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties","volume":"78","author":"Day","year":"2019","journal-title":"Matrix Biol."},{"issue":"35","key":"10.1016\/j.ijbiomac.2025.141903_bb0200","doi-asserted-by":"crossref","first-page":"21292","DOI":"10.1074\/jbc.M115.649855","article-title":"The positively charged COOH-terminal glycosaminoglycan-binding CXCL9 (74\u2013103) peptide inhibits CXCL8-induced neutrophil extravasation and monosodium urate crystal-induced gout in mice","volume":"290","author":"Vanheule","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141903_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/bbrc.1993.1403","article-title":"HuMig: a new human member of the chemokine family of cytokines","volume":"192","author":"Farber","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.141903_bb0210","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1681\/ASN.2006121348","article-title":"Spiegelmer inhibition of CCL2\/MCP-1 ameliorates lupus nephritis in MRL-(Fas) lpr mice","volume":"18","author":"Kulkarni","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.141903_bb0215","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/ijms20081963","article-title":"Glycosaminoglycans and glycosaminoglycan mimetics in cancer and inflammation","volume":"20","author":"Morla","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141903_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01168-19","article-title":"100 years of suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"39","key":"10.1016\/j.ijbiomac.2025.141903_bb0225","doi-asserted-by":"crossref","first-page":"24349","DOI":"10.1016\/S0021-9258(19)51089-4","article-title":"Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells","volume":"269","author":"Yahi","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141903_bb0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41594-021-00570-0","article-title":"Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin","volume":"28","author":"Yin","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.141903_bb0235","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","article-title":"Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening","volume":"3","author":"Zhu","year":"2020","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.141903_bb0240","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1042\/BCJ20210201","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase","volume":"478","author":"Zeng","year":"2021","journal-title":"Biochem. J."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.141903_bb0245","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: a review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141903_bb0250","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijantimicag.2007.11.001","article-title":"In vitro effects of suramin on Trypanosoma cruzi","volume":"31","author":"Bisaggio","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-018-3446-y","article-title":"In vitro s creening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin","volume":"11","author":"Khanra","year":"2018","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0260","series-title":"The Effects of Suramin (Germanin), Azo Dyes, and Vasodilators on Mice With Transplanted Lymphosareomas","author":"Williams","year":"1946"},{"key":"10.1016\/j.ijbiomac.2025.141903_bb0265","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1208\/s12248-014-9703-7","article-title":"Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin","volume":"17","author":"Gan","year":"2015","journal-title":"AAPS J."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.141903_bb0270","first-page":"3303","article-title":"Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer","volume":"9","author":"Villalona-Calero","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.141903_bb0275","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.3390\/molecules28062534","article-title":"Suramin disturbs the association of the N-terminal domain of SARS-CoV-2 nucleocapsid protein with RNA","volume":"28","author":"Guo","year":"2023","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.141903_bb0280","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1021\/acs.jcim.1c00578","article-title":"Targeted redesign of suramin analogs for novel antimicrobial lead development","volume":"61","author":"Dey","year":"2021","journal-title":"J. Chem. Inf. Model."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025024547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025024547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:49:22Z","timestamp":1762238962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025024547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"alternative-id":["S0141813025024547"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141903","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the molecular interactions between monocyte chemoattractant protein and its potential inhibitor suramin","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141903"}}